Posted On: 03/02/2014 7:29:05 PM
Post# of 6

AVMXF Recent News
Avita Medical Announces Completion of Enrollment in ReCell(R) Trial for Vitiligo Marketwire - Wed Aug 21, 7:01AM CDT
Avita Medical Enrolls First Patients in ReCell(R) Trial for Chronic Leg Ulcers Marketwire - Thu Aug 01, 8:30AM CDT
Granted Japanese Patent Expands Commercial Rights for ReCell(R) Spray-On Skin(R) Technology in Asia Marketwire - Wed Apr 10, 8:30AM CDT
Avita Medical Announces Completion of Enrollment in ReCell(R) Trial for Vitiligo Marketwire - Wed Aug 21, 7:01AM CDT
Avita Medical Enrolls First Patients in ReCell(R) Trial for Chronic Leg Ulcers Marketwire - Thu Aug 01, 8:30AM CDT
Granted Japanese Patent Expands Commercial Rights for ReCell(R) Spray-On Skin(R) Technology in Asia Marketwire - Wed Apr 10, 8:30AM CDT

